Filing Details

Accession Number:
0001140361-11-051579
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-03 13:43:45
Reporting Period:
2011-11-01
Filing Date:
2011-11-03
Accepted Time:
2011-11-03 13:43:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301173 H Jeffrey Cooper C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Svp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-10-31 228 $13.23 40,104 No 5 A Direct
Common Stock Disposition 2011-11-01 2,500 $14.39 42,604 No 4 M Direct
Common Stock Disposition 2011-11-01 2,500 $33.26 40,104 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2011-11-01 2,500 $0.00 2,500 $14.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
264,578 2009-11-12 2019-05-11 No 4 M Direct
Footnotes
  1. The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 29, 2011 to October 31, 2011.
  2. Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 7, 2011.
  3. Original option grant vested 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter.